Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04497584
Title Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

lung squamous cell carcinoma

Therapies

Afatinib + Prednisone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.